Last reviewed · How we verify
NCT07111624
A New Crowding Indicator in the Emergency Department
trial in Emergency Department in 828 participants. Not yet recruiting.
31 August 2026
Quick facts
| Lead sponsor | Mario Negri Institute for Pharmacological Research |
|---|---|
| Status | Not yet recruiting |
| Study type | OBSERVATIONAL |
| Enrollment | 828 |
| Start date | 1 September 2025 |
| Primary completion | 31 August 2026 |
| Estimated completion | 31 August 2026 |
| Sites | 10 locations across Italy |
Conditions studied
- Emergency Department — all drugs for Emergency Department →
- Crowding — all drugs for Crowding →
Sponsor
Mario Negri Institute for Pharmacological Research
Who can join
Eligibility, any sex, with Emergency Department or Crowding. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Fenice has proposed a new indicator to measure the level of crowding in the ER. The aim of this study is to evaluate, in a national multicenter context, the degree of agreement between the Fenice indicator and the perception of crowding of the ER operators and to compare this agreement with that between NEDOCS and the perception of the operators.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT07111624
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Emergency Department
Currently open trials in the same condition.
- NCT06408142 — Universal Test and Connect for HIV Service Delivery in South Africa · recruiting
- NCT07034287 — Modifying the Geriatric Acute & Post-acute Care Coordination Program for Fall Prevention in the Emergency Department for · NA · recruiting
- NCT06219486 — The Safe Fast Track Study · NA · recruiting
- NCT06165081 — The Association Between Post-resuscitation Time Series Management in the Emergency Department and Short-term Outcomes fo · recruiting
Other Mario Negri Institute for Pharmacological Research trials
Trials by the same sponsor.
- NCT07428018 — Pragmatic Study to Optimize Neoadjuvant Treatment and Surgical De-escalation in HR+/HER2- Early Breast Cancer Using Onco · Phase 2 · not yet recruiting
- NCT07331103 — RESOLving INflammation Through Diet for Health (RESOLVIN) · NA · recruiting
- NCT06994468 — Effect of B-cell Depleting Therapies on PLA2R-specific B Cells in Patients With Membranous Nephropathy · NA · completed
- NCT07021118 — Mild TBI in the Emergency Department · not yet recruiting
- NCT06594367 — A Possible Founding PKD2 Mutation Associated With Variable Phenotypes of ADPKD in Bergamo Province · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07111624 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Mario Negri Institute for Pharmacological Research
- Last refreshed: 8 August 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07111624.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing